Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06629389
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-30
Brief Title:
Clinical Trial with Cannabidiol Kanbis for Parkinson Disease Symptoms
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Randomized Double-blind Placebo-controlled Phase II Clinical Trial to Evaluate Safety and Tolerability of Cannabidiol Kanbis for the Treatment of Parkinsonamp39s Disease Symptoms
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CBD-EP-2
Brief Summary:
Parkinson disease PD is a chronic progressive neurodegenerative disorder characterized by clinical motor and non-motor symptoms Knowing the potential benefits has led to the use of cannabis as an alternative therapy
Detailed Description:
To evaluate safety and tolerability of CBD-based drug product at different doses
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None